Q4 2025 Earnings Call March 12, 2026 4:30 PM EDTCompany ParticipantsJennie WillsonJacqueline Shea - CEO, President ...
A gene called FOXJ1 may drive resistance to taxane chemotherapy during treatment for advanced prostate cancer, according to a new study led by investigators at Weill Cornell Medicine and Beth Israel ...
Wearable sensors combined with AI offer a novel approach to continuous monitoring of cognitive and emotional health, detecting early changes in brain function.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果